FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 336:677-682 March 6, 1997 Number 10 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Local complications that require additional surgical procedures are an important problem for women with breast implants.

Methods We studied 749 women who lived in Olmsted County, Minnesota, and received a first breast implant at the Mayo Clinic between 1964 and 1991. We identified complications that occurred after the initial procedure and after any subsequent implantation. A complication was defined as a surgical procedure performed for any of the following reasons: capsular contracture; rupture of the implant; hematoma or bleeding; infection or seroma of the wound; chronic pain; extrusion, leakage, or sweating of the implant; necrosis of the nipple, areola, or flap; malfunction of the filler port of a tissue expander; and wound dehiscence.

Results During follow-up (mean, 7.8 years; range, 0 to 25.8), 208 (27.8 percent) of the women underwent 450 additional implant-related surgical procedures. Ninety-one (20.2 percent) were anticipated, staged procedures or were done because the patient requested a size change or aesthetic improvement, and 359 procedures (79.8 percent) had at least one clinical indication (thus constituting a complication). Complications occurred in 178 (23.8 percent) of the 749 women and involved 274 (18.8 percent) of the 1454 breasts with implants and 321 (18.8 percent) of the 1703 implants. The most frequent problem was capsular contraction (131 women), followed by implant rupture (43 [5.7 percent]), hematoma (43), and wound infection (19). The rate of complications was significantly lower (P<0.001) among women with cosmetic implants (6.5 percent at one year, 12 percent at five years) than among those who received implants after mastectomy for breast cancer (21.8 percent at one year, 34 percent at five years) or prophylactic mastectomy (17.3 percent at one year, 30.4 percent at five years).

Conclusions Women who have had breast implantation frequently experience local complications during the subsequent five years. Complications were significantly less frequent among patients who received implants for cosmetic reasons than among those who received implants after mastectomy for cancer or for cancer prophylaxis.

Source Information

From the Division of Rheumatology and Internal Medicine (S.E.G.), the Department of Health Sciences Research (S.E.G., W.M.O., C.M.B., L.T.K., L.J.M.), and the Division of Plastic Surgery (J.E.W.), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Address reprint requests to Dr. Gabriel at the Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Full Text of this Article

This article has been cited by other articles:

• Sarwer, D. B., Brown, G. K., Evans, D. L. (2007). Cosmetic Breast Augmentation and Suicide. Am. J. Psychiatry 164: 1006-1013 [Abstract] [Full Text]  
• Henriksen, T. F., Fryzek, J. P., Holmich, L. R., McLaughlin, J. K., Krag, C., Karlsen, R., Kjoller, K., Olsen, J. H., Friis, S. (2005). Reconstructive Breast Implantation After Mastectomy for Breast Cancer: Clinical Outcomes in a Nationwide Prospective Cohort Study. Arch Surg 140: 1152-1159 [Abstract] [Full Text]  
• Barton, M. B., West, C. N., Liu, I.-L. A., Harris, E. L., Rolnick, S. J., Elmore, J. G., Herrinton, L. J., Greene, S. M., Nekhlyudov, L., Fletcher, S. W., Geiger, A. M. (2005). Complications Following Bilateral Prophylactic Mastectomy. J Natl Cancer Inst Monogr 2005: 61-66 [Abstract] [Full Text]  
• Agnantis, N. J., Paraskevaidis, E., Roukos, D. (2004). Editorial: Preventing Breast, Ovarian Cancer in BRCA Carriers: Rational of Prophylactic Surgery and Promises of Surveillance. Ann. Surg. Oncol. 11: 1030-1034 [Full Text]  
• Darouiche, R. O. (2004). Treatment of Infections Associated with Surgical Implants. NEJM 350: 1422-1429 [Full Text]  
• Roukos, D. H., Agnanti, N. J., Paraskevaidis, E., Kappas, A. M. (2002). Approaching the Dilemma Between Prophylactic Bilateral Mastectomy or Oophorectomy for Breast and Ovarian Cancer Prevention in Carriers of BRCA1 or BRCA2 Mutations. Ann. Surg. Oncol. 9: 941-943 [Full Text]  
• GAGNE, P., McGAUGHEY, D. (2002). Designing Women: Cultural Hegemony and the Exercise of Power among Women Who Have Undergone Elective Mammoplasty. Gender Society 16: 814-838 [Abstract]  
• Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., Norton, L., Castiel, M., Nafa, K., Offit, K. (2002). Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation. NEJM 346: 1609-1615 [Abstract] [Full Text]  
• Gaubitz, M., Jackisch, C., Domschke, W., Heindel, W., Pfleiderer, B. (2002). Silicone breast implants: correlation between implant ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatology (Oxford) 41: 129-135 [Abstract] [Full Text]  
• Meijers-Heijboer, H., van Geel, B., van Putten, W. L.J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B.E., Bartels, C. C.M., Verhoog, L. C., van den Ouweland, A. M.W., Niermeijer, M. F., Brekelmans, C. T.M., Klijn, J. G.M. (2001). Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation. NEJM 345: 159-164 [Abstract] [Full Text]  
• Brown, S. L., Middleton, M. S., Berg, W. A., Soo, M. S., Pennello, G. (2000). Prevalence of Rupture of Silicone Gel Breast Implants Revealed on MR Imaging in a Population of Women in Birmingham, Alabama. Am. J. Roentgenol. 175: 1057-1064 [Abstract] [Full Text]  
• Eisen, A., Rebbeck, T. R., Wood, W. C., Weber, B. L. (2000). Prophylactic Surgery in Women With a Hereditary Predisposition to Breast and Ovarian Cancer. JCO 18: 1980-1995 [Abstract] [Full Text]  
• Middleton, M. S., McNamara, M. P. Jr (2000). Breast Implant Classification with MR Imaging Correlation. RadioGraphics 20: e1-e1 [Abstract] [Full Text]  
• Luzzati, R., Sanna, A., Allegranzi, B., Nardi, S., Berti, M., Barisoni, D., Concia, E. (2000). Pharmacokinetics and tissue penetration of vancomycin in patients undergoing prosthetic mammary surgery. J Antimicrob Chemother 45: 243-245 [Abstract] [Full Text]  
• Vogel, H. (1999). Pathologic findings in nerve and muscle biopsies from 47 women with silicone breast implants. Neurology 53: 293-293 [Abstract] [Full Text]  
• Roger, V V., Jacobsen, S J, Weston, S A, Gabriel, S E (1999). Sex differences in the epidemiology and outcomes of heart disease: population-based trends. Lupus 8: 346-350 [Abstract]  
• (1997). Local Complications with Breast Implants. JWatch Women's Health 1997: 19-19 [Full Text]  
• (1997). COMPLICATIONS AFTER BREAST IMPLANTATION. JWatch General 1997: 1-1 [Full Text]  
• Mathes, S. J. (1997). Breast Implantation -- The Quest for Safety and Quality. NEJM 336: 718-719 [Full Text]  
• Black, B. (1997). Subpoenas and Science -- When Lawyers Force Their Way into the Laboratory. NEJM 336: 725-727 [Full Text]